Clinical Trials Browser

pemigatinib × 30 days × Clear all

NCT07434843 2026-05-22

PEMIGIST

Phase 2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06302621 2026-05-15

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Phase 1 Recruiting

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma